Small molecule therapeutic for lupus
This novel small molecule inhibits ARID3a and results in inhibition of IFNa levels, thereby having the potential for use in treatment of lupus. This technology presents a novel method for segregating patients with increased disease activity and for treatment due to inflammation resulting from IFNa and autoantibody production.
- 17828525.0 (Europe)
- 16/317,719 (US)